Search hospitals > Wisconsin > Milwaukee

Froedtert and The Medical College of Wisconsin

Claim this profile
Milwaukee, Wisconsin 53226
Global Leader in Breast Cancer
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Lymphoma
Conducts research for Myeloid Leukemia
Conducts research for Multiple Myeloma
428 reported clinical trials
53 medical researchers
Photo of Froedtert and The Medical College of Wisconsin in MilwaukeePhoto of Froedtert and The Medical College of Wisconsin in MilwaukeePhoto of Froedtert and The Medical College of Wisconsin in Milwaukee

Summary

Froedtert and The Medical College of Wisconsin is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Breast Cancer, Adult T-Cell Leukemia/Lymphoma, Lymphoma, Myeloid Leukemia, Multiple Myeloma and other specialties. Froedtert and The Medical College of Wisconsin is involved with conducting 428 clinical trials across 607 conditions. There are 53 research doctors associated with this hospital, such as Binod Dhakal, MD, William Bradley, MD, John Charlson, MD, and Jonathan Thompson, MD.

Area of expertise

1Breast Cancer
Global Leader
Froedtert and The Medical College of Wisconsin has run 68 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
Stage III
2Adult T-Cell Leukemia/Lymphoma
Global Leader
Froedtert and The Medical College of Wisconsin has run 49 trials for Adult T-Cell Leukemia/Lymphoma. Some of their research focus areas include:
HLA-A negative
HLA-A positive
HLA positive

Top PIs

Clinical Trials running at Froedtert and The Medical College of Wisconsin

Lymphoma
Breast Cancer
Esophageal Cancer
Pancreatic Cancer
Myelodysplastic Syndrome
Non-Small Cell Lung Cancer
Solid Tumors
Liver Cancer
Adult T-Cell Leukemia/Lymphoma
Acute Myeloid Leukemia
Image of trial facility.

Loncastuximab Tesirine + Chemotherapy

for Lymphoma

The overarching hypothesis for this study is that a safe and tolerable dose (i.e., the maximum tolerated dose) will be identified for loncastuximab tesirine in combination with dose-adjusted etoposide phosphate, prednisone, vincristine sulfate (Oncovin), cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), and rituximab (DA-EPOCH-R) for patients with previously untreated aggressive B-cell lymphoid malignancies.
Recruiting1 award Phase 1
Image of trial facility.

Voruciclib + Venetoclax

for Leukemia and Lymphoma

This is a Phase 1, open-label, dose escalation study to determine the safety and preliminary efficacy of voruciclib monotherapy in subjects with relapsed/refractory B cell malignancies or AML after failure of standard therapies or voruciclib in combination with venetoclax in subjects with relapsed or refractory AML
Recruiting1 award Phase 1
Image of trial facility.

Cell Therapy

for Non-Hodgkin's Lymphoma

This trial tests a new treatment where a patient's own immune cells are enhanced to fight difficult-to-treat lymphoma. It targets patients whose cancer hasn't responded to at least two other treatments. The modified cells aim to better recognize and attack the cancer. This new method improves the ability of the patient's immune cells to find and destroy cancer cells.
Recruiting1 award Phase 219 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Froedtert and The Medical College of Wisconsin?
Where is Froedtert and The Medical College of Wisconsin located?
Who should I call to ask about financial aid or insurance network?
What insurance does Froedtert and The Medical College of Wisconsin accept?
What awards or recognition has Froedtert and The Medical College of Wisconsin received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security